Browse every published article, from the latest research to earlier analysis. Use the page numbers below to explore the complete archive.
Having the drug available is different from having a complete sedation service.
Affinity, maximal effect and concentration sensitivity can lead to different selectivity descriptions.
A same-time medication association cannot determine whether exposure preceded frailty.
A favorable final outcome does not isolate which component of a complex resuscitation produced it.
An adjusted association can still reflect the illness and treatment context in which a medicine is used.
Antiseizure medication after poisoning does not independently establish a chronic epilepsy diagnosis.
A reduction in treatment days cannot be assigned to one component of a multicomponent care change.
A medicine administered during resuscitation must be distinguished from the substance ingested beforehand.
Antagonist sensitivity does not by itself show that an odorant directly binds a benzodiazepine site.
Receptor imaging and therapeutic response are different kinds of evidence.
A null-compatible estimate should not be rewritten as either established harm or established safety.
The trial compared two induction strategies, not midazolam alone against dexmedetomidine alone.
An apparent table–text discrepancy may require separating prehospital treatment from emergency-department treatment.
Clinicians may overestimate as well as underestimate how difficult a patient expects dose reduction to be.
A planned noninferiority test is not a finding of equal safety.
Evidence for short-term symptom control does not automatically support continuing the same medicine indefinitely.
A tablet’s appearance or reported name is weaker evidence of composition than an appropriately targeted chemical analysis.
A proposed detection technology does not establish analytical reliability in an individual investigation.
The protocol describes how a recovery question will be tested; it does not report that either strategy won.
Practice variation describes uncertainty and local choices rather than demonstrating comparative effectiveness.
An adjusted protective association is not proof that the sedative prevented delirium.
A rescue benzodiazepine on the chart may follow the event rather than cause it.
Calling a medicine intranasal does not establish that different formulations deliver equivalent exposure.
Citation ranking is useful for historical orientation but is not a quality hierarchy.
A self-controlled design still depends on measuring exposure during relevant periods.
A publication hotspot can identify a research topic without establishing its clinical validity.
A successful combined course cannot establish benzodiazepine monotherapy as the effective treatment.
Medication counts fell during follow-up, but the study lacked an untreated comparison.
The pooled result favored remimazolam, but its precision varied substantially across outcomes.
The probability of crossing a threshold and the time spent below it are different outcomes.